MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
T2 Biosystems Cash and Cash Equivalents 2011-2026 | TTOO
Annual Cash and Cash Equivalents T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.7 M | 10.3 M | 22.2 M | 16.8 M | 11 M | 50.8 M | 41.8 M | 73.5 M | 73.7 M | 73.8 M | 30.2 M | 9.71 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 73.8 M | 9.71 M | 35.8 M |
Quarterly Cash and Cash Equivalents T2 Biosystems
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.08 M | 4.25 M | 6.21 M | 15.7 M | 24.3 M | 16.1 M | 10.1 M | 10.3 M | 20.4 M | 13.2 M | 9.4 M | 22.2 M | 22 M | 32.7 M | 10.7 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 11 M | 11 M | 11 M | 11 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 41.8 M | 41.8 M | 41.8 M | 41.8 M | 73.5 M | 73.5 M | 73.5 M | 73.5 M | 73.7 M | 73.7 M | 73.7 M | 73.7 M | 73.8 M | 73.8 M | 73.8 M | 73.8 M | 30.2 M | 30.2 M | 30.2 M | - | 9.71 M | - | - | - | 18.7 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 73.8 M | 2.08 M | 35.5 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.48 B | $ 115.62 | 0.06 % | $ 35.1 B |  USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 24.98 | 2.13 % | $ 694 M | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 21.85 | 2.92 % | $ 1.16 B | USA |
 |
Illumina
ILMN
|
1.13 B | $ 128.52 | 0.5 % | $ 20.4 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 15.6 | -4.35 % | $ 472 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
359 M | $ 84.11 | -0.26 % | $ 5.68 B | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 171.23 | 0.86 % | $ 8.49 B | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 421.37 | 2.64 % | $ 12.2 B | USA |
 |
Guardant Health
GH
|
378 M | $ 88.5 | -0.46 % | $ 11.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 27.54 | 0.25 % | $ 20 B |  Niderland |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Personalis
PSNL
|
91.4 M | $ 5.96 | -2.3 % | $ 353 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 7.27 | 3.12 % | $ 303 M | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Soleno Therapeutics
SLNO
|
70.1 M | $ 52.75 | 0.06 % | $ 2.68 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
129 M | $ 9.45 | -0.94 % | $ 2.05 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.18 | 1.87 % | $ 5.01 M | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 17.11 | -0.7 % | $ 383 M | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 468.04 | -0.36 % | $ 176 B | USA |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 103.21 | 1.02 % | $ 8.51 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 263.43 | -0.12 % | $ 21.9 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.64 | -0.82 % | $ 61.9 M | Irlanda |
 |
Celcuity
CELC
|
166 M | $ 125.68 | 3.84 % | $ 5.88 B | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 61.0 | 0.1 % | $ 3.65 B | USA |
 |
OpGen
OPGN
|
1.31 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 8.61 | 3.86 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.83 | 1.05 % | $ 447 M | USA |
 |
Natera
NTRA
|
466 M | $ 204.39 | 0.31 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 196.63 | 0.21 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | USA |